4.4 Review

The first influenza pandemic of the new millennium

Journal

INFLUENZA AND OTHER RESPIRATORY VIRUSES
Volume 5, Issue 3, Pages 157-166

Publisher

WILEY
DOI: 10.1111/j.1750-2659.2011.00231.x

Keywords

Antiviral compounds; H1N1; influenza virus; pandemic; reassortment; vaccines

Funding

  1. National Institute of Allergy and Infectious Diseases Public Health Service
  2. NIAID [HHSN266200700010C]
  3. Ministry of Education, Culture, Sports, Science, and Technology
  4. Ministry of Health, Japan
  5. ERATO (Japan Science and Technology Agency)

Ask authors/readers for more resources

In the spring of 2009, a novel influenza A virus of the H1N1 subtype emerged that transmitted efficiently among humans; by June of 2009, the outbreak reached pandemic status. The pandemic virus possesses six viral RNA segments from so-called triple reassortant swine viruses that emerged in North American pig populations in the late 1990s and two viral RNA segments from Eurasian avian-like swine influenza viruses. Most human infections with the virus have been mild; however, severe and fatal infections occurred among certain risk groups, but also among those without any known risk factors. Here, we summarize the evolutionary, epidemiological, clinical, and molecular findings on the pandemic virus. We also discuss the arsenal of antiviral compounds and vaccines available to prevent and treat infections with the virus.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available